Leading cancer care from prevention to survivorship with advanced research, individualized treatment, and dedicated care coordination support.

St. Louis, MO
Joined November 2009
When cancer is complex, where you go matters. Siteman Cancer Center at Barnes-Jewish Hospital and @washumedicine: 700+ physicians and researchers, one of the largest clinical trial programs, rated “Exceptional” by @theNCI. Redefining what it means to live with and beyond cancer.
104
Today we recognize Metastatic Breast Cancer Awareness Day.
1
2
6
528
Living with metastatic breast cancer takes more than clinical care — it takes community. Siteman Cancer Center’s MBC Empowerment Initiative connects patients with resources, support groups and a team that understands. @WashUMedicine siteman.washu.edu/how-sitema…
2
4
108
Congratulations to @WashUMedicine's Bettina F. Drake, PhD, MPH, on being installed as the Michael F. Neidorff Professor of Surgery in the Division of Public Health Sciences at WashU Medicine and Siteman Cancer Center. Congratulations, Dr. Drake.
1
179
Less than 1% of adult cancer diagnoses. 13 years of fundraising. $1.7 million raised. The @STLCureSarcoma 6K returns Oct. 11 at Creve Coeur Park supporting sarcoma research at @washumedicine and Siteman Cancer Center. siteman.washu.edu/building-o…
371
Closing out @ASTRO_org 2026 in Boston. Here are our @washumedicine presenters for the day from Siteman Cancer Center. #ASTRO26 has been a great conference! See you at #ASTRO27!
1
337
Congratulations to @washumedicine's Carmen Bergom, MD, PhD, FACS, on being officially inducted into the @ASTRO_org Class of 2026 Fellows today in Boston. Bergom is a radiation oncologist and research member at Siteman Cancer Center. siteman.washu.edu/bergom-nam… #ASTRO26
2
5
492
Day 4 at @ASTRO_org in Boston. Here are our @washumedicine presenters for the day from Siteman Cancer Center. #ASTRO26
6
384
Congratulations to @washumedicine's Timothy J. Eberlein, MD, FACS, founding director of Siteman Cancer Center, on being installed as the 107th president of @AmCollSurgeons, the world's largest organization of surgeons. siteman.washu.edu/timothy-j-…
1
2
427
So proud of our team, who played a leading role in the multi-year development of #Accela with @samsonpp serving as physician lead of the international advisory group! Thrilled & excited to see how this new technology will help patients @SitemanCenter & around the world. #ASTRO26
2
4
16
955
We're back for Day 3 at @ASTRO_org in Boston. Here's who's presenting today from @washumedicine and Siteman Cancer Center. #ASTRO26
1
1
509
Day 2 at @ASTRO_org in Boston! Here are our @washumedicine presenters for the day from Siteman Cancer Center. #ASTRO26
1
403
We're excited to present at the @ASTRO_org Annual Meeting 2026, kicking off today in Boston! Here are our @washumedicine presenters for the day from Siteman Cancer Center.
1
2
479
Congratulations to @washumedicine's Wilson Zachary Ray, MD, on being named one of @BeckersASC's 20 Neurosurgeons to Know. Dr. Ray is chief of spine surgery and, at Siteman Cancer Center, specializes in the treatment of spinal cord tumors. beckersasc.com/asc-news/20-n…
4
409
Congratulations to @washumedicine's Jessica Silva-Fisher, PhD, on receiving a Research Scholar Grant from @AmericanCancer, one of only 15 selected nationally. Her work at Siteman focuses on multiple myeloma treatment resistance. siteman.wustl.edu/jessica-si…
5
10
441
Congratulations to @washumedicine's Lannis Hall, MD, MPH, on receiving the 2026 Guardian Angel Award from The Empowerment Network for her dedication to prostate cancer patients and survivors at Siteman Cancer Center. siteman.wustl.edu/hall-recog…
2
3
329
Replying to @washumedicine
@washumedicine's Kian-Huat Lim, MD, PhD, at Siteman Cancer Center joined @KMOV to discuss pancreatic cancer research, the symptoms to watch for and the treatments available. Watch: firstalert4.com/video/2026/0…
1
3
10
459
Since this interview, the FDA has approved darovasertib, a first-in-class drug for metastatic pancreatic cancer. Dr. Lim served as our site principal investigator for the international Phase 3 clinical trial. siteman.washu.edu/newly-appr…
54